- Home
- CTRM vs CRIS Comparison
CTRM vs CRIS Comparison
Compare CTRM & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTRM
- CRIS
- Stock Information
- Founded
- CTRM 2016
- CRIS 2000
- Country
- CTRM Cyprus
- CRIS United States
- Employees
- CTRM N/A
- CRIS N/A
- Industry
- CTRM Marine Transportation
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CTRM Consumer Discretionary
- CRIS Health Care
- Exchange
- CTRM Nasdaq
- CRIS Nasdaq
- Market Cap
- CTRM 20.7M
- CRIS 21.3M
- IPO Year
- CTRM N/A
- CRIS 2000
- Fundamental
- Price
- CTRM $2.32
- CRIS $2.39
- Analyst Decision
- CTRM
- CRIS Strong Buy
- Analyst Count
- CTRM 0
- CRIS 2
- Target Price
- CTRM N/A
- CRIS $16.50
- AVG Volume (30 Days)
- CTRM 62.6K
- CRIS 78.6K
- Earning Date
- CTRM 06-17-2025
- CRIS 07-31-2025
- Dividend Yield
- CTRM N/A
- CRIS N/A
- EPS Growth
- CTRM N/A
- CRIS N/A
- EPS
- CTRM 0.38
- CRIS N/A
- Revenue
- CTRM $66,243,379.00
- CRIS $11,202,000.00
- Revenue This Year
- CTRM N/A
- CRIS $0.93
- Revenue Next Year
- CTRM N/A
- CRIS $8.10
- P/E Ratio
- CTRM $6.23
- CRIS N/A
- Revenue Growth
- CTRM N/A
- CRIS 14.17
- 52 Week Low
- CTRM $1.98
- CRIS $1.02
- 52 Week High
- CTRM $5.49
- CRIS $9.78
- Technical
- Relative Strength Index (RSI)
- CTRM 54.53
- CRIS 60.94
- Support Level
- CTRM $2.30
- CRIS $2.23
- Resistance Level
- CTRM $2.44
- CRIS $2.63
- Average True Range (ATR)
- CTRM 0.11
- CRIS 0.18
- MACD
- CTRM 0.01
- CRIS 0.03
- Stochastic Oscillator
- CTRM 52.76
- CRIS 69.62
About CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under two reportable segments namely Dry bulk; Aframax/LR2 tanker; Handysize tanker and Container ship. It generates maximum revenue from the Dry bulk segment.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.